MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Acquires New Position in The Clorox Company (NYSE:CLX)

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH acquired a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 66,252 shares of the company's stock, valued at approximately $9,756,000. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH owned 0.05% of Clorox as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in CLX. Redwood Park Advisors LLC purchased a new stake in shares of Clorox during the 4th quarter valued at $26,000. Millstone Evans Group LLC purchased a new stake in Clorox during the 4th quarter worth $31,000. Wood Tarver Financial Group LLC purchased a new stake in Clorox during the 4th quarter worth $31,000. Asset Planning Inc purchased a new stake in Clorox during the 4th quarter worth $32,000. Finally, GKV Capital Management Co. Inc. purchased a new stake in Clorox during the 4th quarter worth $32,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Down 3.3%

CLX stock traded down $4.25 during trading on Friday, reaching $123.03. The stock had a trading volume of 1,709,082 shares, compared to its average volume of 1,361,693. The Clorox Company has a 1-year low of $122.84 and a 1-year high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The company has a market capitalization of $15.16 billion, a P/E ratio of 33.61, a PEG ratio of 2.62 and a beta of 0.54. The firm has a fifty day moving average price of $134.91 and a 200 day moving average price of $148.35.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. The business's revenue for the quarter was down 8.0% compared to the same quarter last year. During the same quarter last year, the company posted $1.71 EPS. On average, equities analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Insider Activity

In related news, Director Pierre R. Breber bought 4,000 shares of the business's stock in a transaction dated Wednesday, May 7th. The shares were acquired at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the purchase, the director now owns 4,000 shares in the company, valued at $546,280. This trade represents a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.57% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on CLX. Evercore ISI set a $140.00 price target on shares of Clorox and gave the stock an "underperform" rating in a research report on Tuesday, May 6th. Morgan Stanley decreased their price target on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Barclays decreased their price target on shares of Clorox from $134.00 to $129.00 and set an "underweight" rating for the company in a research report on Wednesday, May 7th. UBS Group decreased their price target on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a research report on Thursday, April 17th. Finally, Wells Fargo & Company cut their price objective on shares of Clorox from $145.00 to $142.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $151.23.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.